Status:
COMPLETED
Evaluation of Remote DBS Programming.
Lead Sponsor:
Thomas Köglsperger
Collaborating Sponsors:
Friedrich-Alexander-Universität Erlangen-Nürnberg
Universitätsklinikum Leipzig
Conditions:
Deep Brain Stimulation
Telemedicine
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
Deep brain stimulation (DBS) represents the treatment of choice for advanced stages of Parkinson's disease (PD). Currently, adaptive closed-loop stimulation systems that apply disease-specific biomark...
Eligibility Criteria
Inclusion
- Age between 35 and 80 yrs.
- Ability to communicate with the study physician and to understand the requirements of the study
- Idiopathic Parkinson's Syndrome; IPS (according to MDS-Criteria)
- Implantation of a DBS device for the stimulation of the subthalamic nucleus (STN) to treat PD.
Exclusion
- Any inability to communicate with the study physician and to understand the requirements of the study
- Exclusion criteria of an idiopathic Parkinson's syndrome (IPS)
- Fulfills the criteria of dementia (according to the International Classification of Diseases (ICD) 10)
Key Trial Info
Start Date :
March 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2025
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05193825
Start Date
March 22 2022
End Date
July 30 2025
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ludwig Maximilian University Hospital
Munich, Bavaria, Germany, 81377